The Science
Pharmaceutical-grade quality, every batch.
EPAVANCE is manufactured under the same conditions as prescription medicines — MHRA-audited, GMP-certified, batch-tested before release. Every pack carries a certificate of analysis.
Manufacturing Standards
Our quality commitments at a glance.
Manufacturing Partner
Made with Sla Health — a pharmaceutical GMP facility.
EPAVANCE is manufactured by Sla Health, a UK pharmaceutical contract manufacturer operating under Good Manufacturing Practice (GMP) as defined by the Medicines and Healthcare products Regulatory Agency (MHRA). The facility is subject to periodic MHRA inspection.
FSMP products are not required to be manufactured to pharmaceutical GMP standards — but EPAVANCE is, as a deliberate choice. We believe the patients using EPAVANCE deserve the same level of manufacturing assurance as patients taking prescription medicines.
-
MHRA-inspected facility
-
Pharmaceutical GMP (EU/UK)
-
Validated manufacturing processes
-
Environmental monitoring programme
Batch Release Testing
Every batch tested before release.
-
EPA purity testing
Each batch is tested by HPLC for EPA purity. Release specification: ≥97% EPA. Batches not meeting specification are rejected and not released.
-
Oxidation testing (TOTOX value)
Omega-3 oils oxidise on exposure to air, heat and light. We test every batch for TOTOX (Total Oxidation Value), peroxide value (PV) and anisidine value (AV). Our specification is stricter than the GOED industry standard.
-
Heavy metals testing
Each batch is screened for lead, mercury, cadmium, and arsenic to EU food safety limits. Results are included in the Certificate of Analysis.
-
Certificate of Analysis (COA) issue
A COA is issued for every batch and is available on request. The COA includes batch number, manufacturing date, test results, and release authorisation signature.
Request a Certificate of Analysis.
Healthcare professionals and patients can request a COA for any current EPAVANCE batch. Contact our quality team with your batch number.